Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2021 07:00 ET | Source: Renalytix AI plc.

Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management...
March 04, 2021 13:00 ET | Source: Renalytix AI plc.

Renalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management...
March 02, 2021 07:00 ET | Source: Renalytix AI plc.

RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021

NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on...
February 24, 2021 08:00 ET | Source: Renalytix AI plc.

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

NEW YORK and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, and the University of...
February 23, 2021 02:00 ET | Source: Renalytix AI plc.

RenalytixAI to announce Financial Results for six and three months ended December 31, 2020

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), the artificial intelligence-enabled in vitro diagnostics company, focused on...
February 04, 2021 07:00 ET | Source: Renalytix AI plc.

American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health

NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
January 13, 2021 02:00 ET | Source: Renalytix AI plc.

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The Centers for Medicaid & Medicare (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway (RIN:...
January 05, 2021 06:00 ET | Source: Renalytix AI plc.

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Kidney care innovators Renalytix AI (NASDAQ:RNLX, LSE:RENX) and DaVita (NYSE: DVA) are partnering on a program aimed at slowing disease progression and...
January 04, 2021 08:05 ET | Source: Renalytix AI plc.

RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
November 25, 2020 07:00 ET | Source: Renalytix AI plc.

RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...